COVID-19
Cardiac-Related Mortality Following COVID-19 Vaccination in Florida
Reference: SA “Vaccine” Injury Medico-Legal Study-Group. (2022). Exploring the relationship between all-cause and cardiac-related mortality following COVID-19 vaccination or infection in Florida residents: a self-controlled case series study. Summary: This study investigates the risks of all-cause and cardiac-related mortality following COVID-19 vaccinations among Florida residents. It reveals that all participants who died did so within
Periodic Safety Update Report on COVID-19 mRNA Vaccine (BNT162b2)
Reference: BioNTech Manufacturing GmbH. (2022). COVID-19 mRNA vaccine (nucleoside modified) Reporting Period Periodic Safety Update Report (PSUR) 3: 19 December 2021 through 18 June 2022. Summary: The third Periodic Safety Update Report (PSUR) for the COVID-19 mRNA vaccine (BNT162b2), also known as COMIRNATY®, covers data from 19 December 2021 to 18 June 2022. It outlines
Evidence of Vascular Damage from mRNA Vaccines
Reference: Palmer, M., & Bhakdi, S. (2022). Vascular and organ damage induced by mRNA vaccines: Irrefutable proof of causality. doctors4covidethics.org. Summary: This article by Palmer and Bhakdi presents alarming findings regarding the safety of mRNA vaccines, particularly in relation to COVID-19. The authors argue that mRNA vaccines do not remain at the injection site but
Vascular and Organ Damage Induced by mRNA Vaccines: Causality Evidence
Reference: Palmer, M., & Bhakdi, S. (2022). Vascular and organ damage induced by mRNA vaccines: Irrefutable proof of causality. doctors4covidethics.org. Summary: The article by Palmer and Bhakdi presents compelling evidence regarding the adverse effects of mRNA vaccines, particularly focusing on their widespread distribution and subsequent impact on organ health. Key findings reveal that mRNA vaccines
Efficacy of Metformin, Ivermectin, and Fluvoxamine in Early COVID-19 Treatment
Reference: Bramante, C. T., Huling, J. D., Tignanelli, C. J., Buse, J. B., Liebovitz, D. M., Nicklas, J. M., Cohen, K., Puskarich, M. A., Belani, H. K., Proper, J. L., Siegel, L. K., Klatt, N. R., Odde, D. J., Luke, D. G., Anderson, B., Karger, A. B., Ingraham, N. E., Hartman, K. M., Rao, V.,
Impact of COVID-19 Vaccination Campaign on Mortality in the USA
Reference: Rancourt, D. G., Baudin, M., & Mercier, J. (2022). COVID-Period Mass Vaccination Campaign and Public Health Disaster in the USA: From age/state-resolved all-cause mortality by time, age-resolved vaccine delivery by time, and socio-geo-economic data. Preprint. Retrieved from https://www.medrxiv.org/ Summary: This article examines the impact of the COVID-19 vaccination campaign on all-cause mortality in the
Serious Adverse Events of Special Interest Following mRNA COVID-19 Vaccination in Randomised Trials
Reference: Fraiman, J., Erviti, J., Jones, M., Greenland, S., Whelan, P., Kaplan, R. M., & Doshi, P. (2022). Serious adverse events of special interest following mRNA COVID-19 vaccination in randomised trials in adults. Vaccine, 40(5), 649-659. https://doi.org/10.1016/j.vaccine.2022.08.036 Summary: This article assesses serious adverse events (SAEs) associated with mRNA COVID-19 vaccines (Pfizer and Moderna) through a
Serious Adverse Events Following mRNA COVID-19 Vaccination: An Analysis of Randomised Trials
Reference: Fraiman, J., Erviti, J., Jones, M., Greenland, S., Whelan, P., Kaplan, R. M., & Doshi, P. (2022). Serious adverse events of special interest following mRNA COVID-19 vaccination in randomised trials in adults. Vaccine, 40(1), 1-9. https://doi.org/10.1016/j.vaccine.2022.08.036 Summary: This article examines the serious adverse events (SAEs) associated with mRNA COVID-19 vaccines (Pfizer and Moderna) as
Impact of COVID-19 on Group Life Mortality: Findings and Insights
Reference: Britt, T. J., Correia, P., Hurley, P., Krohn, M., LaSala, T., Leavitt, R., Lumia, R., MacDonald, C. S., Nolan, P., Rulis, S., & Spector, B. (2022). Group Life COVID-19 Mortality Survey Report. Society of Actuaries Research Institute. Summary: The Group Life COVID-19 Mortality Survey Report, published in August 2022, analyses the impact of the